N. Klein

发表

The Lancet Small Vulnerable Newborn Series: science for a healthy start

J. Lawn, R. Black, P. Ashorn, 2020, The Lancet.

Mannose-Binding Lectin Binds to Two Major

D. Jack, G. Jarvis, M. Estabrook, 2004 .

Neisseria meningitidis and Porin, of Outer Membrane Proteins, Opacity Protein Mannose-Binding Lectin Binds to Two Major

D. Jack, G. Jarvis, M. Estabrook, 2004 .

Endotoxin antibody for sepsis in infants

R. Heyderman, M. Levin, S. Nadel, 1992, The Lancet.

Hyperzincaemia and hypercalprotectinaemia: a new disorder of zinc metabolism

B. Wolska-Kuśnierz, J. Roth, J. Beattie, 2002, The Lancet.

Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

Ana C. Matos, C. Königs, C. Giaquinto, 2022, The lancet. HIV.

Kaposi's sarcoma and KSHV

S. Franceschi, D. Serraino, D. Shingadia, 1995, The Lancet.

Emergency management of meningitis

R. Heyderman, N. Klein, N. Klein, 2000, Journal of the Royal Society of Medicine.

Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial

Ana C. Matos, C. Königs, J. Seeley, 2022, The lancet. HIV.

Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial

J. Seeley, A. Shali, A. Walker, 2018, The lancet. HIV.

Effect of monthly intermittent preventive treatment with dihydroartemisinin–piperaquine with and without azithromycin versus monthly sulfadoxine–pyrimethamine on adverse pregnancy outcomes in Africa: a double-blind randomised, partly placebo-controlled trial

K. Otieno, S. Gesase, G. Mtove, 2023, The Lancet.

Intermittent childhood azithromycin mass drug administration in sub-Saharan Africa: current indications and supporting evidence

M. Sharland, J. Bielicki, J. Berkley, 2019 .

Small babies, big risks: global estimates of prevalence and mortality for vulnerable newborns to accelerate change and improve counting

Julie M. Herlihy, R. Noor, W. Fawzi, 2023, The Lancet.

Small vulnerable newborns—big potential for impact

Gretchen A. Stevens, G. Stevens, J. Lawn, 2023, The Lancet.

The ethical, economic, and developmental imperative to prevent small vulnerable newborns and stillbirths: essential actions to improve the country and global response

J. Lawn, J. Shiffman, E. Langlois, 2023, The Lancet.

Biological and pathological mechanisms leading to the birth of a small vulnerable newborn

J. Lawn, P. Ashorn, A. Ayede, 2023, The Lancet.

Evidence-based antenatal interventions to reduce the incidence of small vulnerable newborns and their associated poor outcomes

N. Walker, J. Lawn, Z. Bhutta, 2023, The Lancet.

Immune repopulation after HAART in previously untreated HIV-1-infected children

N. Klein, D. Gibb, A. Babiker, 2000, The Lancet.

Infection and sudden unexpected death in infancy: a systematic retrospective case review

N. Sebire, N. Sebire, J. Hartley, 2008, The Lancet.

Association Between Human Immunodeficiency Virus Viremia and Compromised Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Beta Variant

T. Ndung’u, A. Sigal, P. Goulder, 2022, The Journal of Infectious Diseases.